Substituted 8-[6-amino-3-pyridyl]xanthines
US7884100B2 · kind B2 · utility
6Cited by
15References
48Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 12, 2007 |
| Grant date | Feb 8, 2011 |
| Priority date | — |
| Expiry date | Jul 24, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides substituted 8-[6-amino-3-pyridyl]xanthines like the compound shown in the following formula:and pharmaceutical compositions that are selective antagonists of A2B adenosine receptors (ARs). These compounds and compositions are useful as pharmaceutical agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.